Free Disclosure Statement - District Court of Delaware - Delaware

Case 1 :06-cv-00741-SLR Document 7 Filed 12/08/2006 Page 1 of 3
UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF DELAWARE
)
CELGENE CORPORATION, NOVARTIS )
PHARMACEUTICALS CORPORATION and )
NOVARTIS PHARMA A.G., )
)
Plaintiffs )
v. ) Civil Action No.1:06-cv-00741-UNA
)
ABRIKA PHARMACEUTICALS, INC., and )
ABRIKA PHARMACEUTICAL, LLLP, )
)
Defendants. )

RULE 7.1 DISCLOSURE STATEMENT
Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure and to enable district
judges and magistrate judges of the Court to evaluate possible disqualification or recusal,
the undersigned counsel for Abrika Pharmaceuticals, Inc. and Abrika Pharmaceutical,
LLLP certifies that neither Abrika Pharmaceuticals, Inc., a Delaware corporation, nor
Abrika Pharmaceutical, LLLP, a Florida limited liability limited partnership, has a parent
corporation. No publicly held corporation owns 10 percent or more of the stock of either
Abrika Pharmaceuticals, Inc. or Abrika Pharmaceutical, LLLP.
/s/ Andre G. Bouchard
Andre G. Bouchard (#2504) [abouchard@bmf—law.com]
John M. Seaman (#3868) |[email protected]]
Boucu/mo MARoULEs & FPJEDLANDER, P.A.
222 Delaware Avenue, Suite 1400
Wilmington, DE 19801
(302) 573-3500
Attarneysfar Dekndants Abrika Pharmaceuticals, Inc.
and Abrika Pharmaceutical, LLLP
{BMF-woosssss.}

Case 1:06-cv—00741-SLR Document 7 Filed 12/08/2006 Page 2 of 3
OF COUNSEL:
James D. Veltrop
Jonathan A. Harris
Chad A. Landmon
Jo-Anne M. Kokoski
AXINN, VELTROP &
HARKRIDER LLP
90 State House Square
Hartford, CT 06103-3702
(860) 275-8100
Dated: December 8, 2006
{EMF-woosssss.}

Case 1:06-cv—00741-SLR Document 7 Filed 12/08/2006 Page 3 of 3
CERTIFICATE OF SERVICE
I, Andre G. Bouchard, hereby certify that on December 8, 2006, I caused to be
electronically tiled a true and correct copy of the notice of the foregoing document —Defendants’
Rule Z1 Disclosure Statement with the Clerk of Court using CM/ECF which will send
notification of such tiling to the following counsel of record:
Philip A. Rovner, Esquire
Potter Anderson & Corroon
1313 N. Market Street
Wilmington, DE 19801
pr0vner@p0tteranders0n. c0m
1 further certify that on December 8, 2006, I caused copies of the foregoing document to
be served by e-mail on the above-listed counsel and on the following non-registered participants.
Anthony M. Insogna, Esquire F. Dominic Cerrito, Esquire
Lester J. Savit, Esquire Jones Day
Nicholas N. Kallas, Esquire 222 East 41st Street
12750 High Bluff Drive, Suite 300 New York, NY 10017-6702
San Diego, CA 92130-2083 fa'cerrit0@j0nesa’ay.c0m
am ins0gna@j0rzesa’ay. com
Usavit@i0nesday cam
Robert L. Baechtold, Esquire
Hem·y J. Renk, Esquire
Jones Day
Fitzpatrick, Cella Harper & Scinto
30 Rockefeller Plaza
New York, NY 10112
rbaecht0la'@fchs. c0m
hrerzk@fchs. c0m
nkallas@fchs. c0m
/s/ Andre G. Bouchard
Andre G. Bouchard (#2504) [[email protected]]
Boucrmrro MARouLEs & FRrEor.ANDER, P.A.
222 Delaware Avenue, Suite 1400
Wilmington, DE 19801
(302) 573-3500
Attorneys for Dejendants Abrika Pharmaceuticals, Inc.
and Abrika Pharmaceutical, LLLP
{BMP-w0033s44.}